Measles – Historic Perspective on Disease Impact and Vaccine Development
Robert Atmar, Baylor College of Medicine

Antimicrobial Resistance: The Silent Global Threat
Denise Cardo, Centers for Disease Control and Prevention

Exploiting Strain Richness Limits for Targeted Alteration of the gut Microbiome
Jeremiah Faith, Mount Sinai / Icahn Genomics Institute

Measles – Factors Impacting Population Immunity
Hana El Sahly, Baylor College of Medicine

Prevalence and Genetics of cefepime resistance among the AmpC-producing organisms Citrobacter freundii, Enterobacter cloacae, and Klebsiella aerogenes
Sarah Schrader, Massachusetts General Hospital / Brigham and Women’s Hospital

C. difficile in Pediatrics
Barbara Trautner, Washington University at St Louis

Sepsis Opportunities and Challenges in the Earliest Care Moments
Donald Yealy, Univ. of Pittsburgh Schools of the Health Sciences

A Pharmacological View of Antibiotic Discovery
David Andes, University of Wisconsin

Antimicrobial Stewardship Challenges in Immunocompromised Patients
Jovan Borjan, MD Anderson Cancer Center

FAST Trial
Ritu Banerjee, Vanderbilt University

Bactericidal Monoclonal Antibodies Against Lipopolysaccharide Protect Against Pseudomonas Aeruginosa Challenge in Mice
Mariette Barbier, West Virginia University

Mechanisms and Consequences of PasTI-mediated Bacterial Stress Resistance and Persistence
Taylor Blackburn, University of Pittsburgh

C. difficile in Pediatrics
Travis Carlson, University of Texas Health Science Center

Enterococcus Colonization Impact on C. difficile Disease Severity
Taryn Eubank, University of Houston

Emerging Therapies for Clostridioides difficile Infection
Kevin Garey, University of Houston

Pneumonia Direct Pilot
Kim Hanson, University of Utah and ARUP Laboratories

Decolonization in Long-Term Care to Address Infections, Hospitalizations, and MDROs
Susan Huang, UC Irvine

ID Myths Part II
Melissa Johnson, Duke University

Applications of Machine Learning to Support Antimicrobial Stewardship
Sanjat Kanjilal, Harvard Medical School

Peer Review and Advancing the Science of Stewardship
Preeti Malani, University of Michigan

Infection in Pediatric Transplants
Elizabeth A. Moulton, Baylor College of Medicine

Mitigating the Spread of Antimicrobial Resistance in Healthcare Settings through Real-time Genomic Surveillance of Bacterial Plasmids
Nathan Raabe, University of Pittsburgh

MDRO Colonization in ICU Patients: Results from the DYNAMITE Cohort Study
Max Adelman, Houston Methodist

Applications of Caenorhabditis elegans for Identification of Treatments Against Antimicrobial-Resistant Bacteria
Lois Armendariz, Rice University

RSV Vaccines: Moving on to Recommendations
Robert Atmar, Baylor College of Medicine

Neonatal Stewardship
Michael Chang, Univ. of Texas Health Science Center Houston

Differences in Virulence Between the Two Clades of Multidrug-Resistant K. Pneumoniae ST258
Nathalie Chen, Univ. of Pittsburgh

Resistance and New Drugs for Mycobacterium Tuberculosis
Kelly Dooley, Vanderbilt Univ. Medical Center

In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) Inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy

Chetna Dureja, Texas A&M University Institute of BioSciences and Technology

Cefepime Heteroresistance is Prevalent Among Clinical Pseudomonas Aeruginosa Bloodstream Isolates and is Associated with Emergence of Resistance in Patients with Hematologic Malignancies
Stephanie Egge, Oregon Health & Science University

RSV Vaccines: The Road to Licensure
Hana El Sahly, Baylor College of Medicine

Antibiotic Resistance in Neisseria Gonorrhoeae
Yonatan Grad, Harvard School of Public Health, Boston, MA

DOOR Application Demonstration
Toshimitsu Hamasaki, George Washington University

Understanding the Molecular Epidemiology of Non-CTX-M ESBL-producing Enterobacterales in the MidAtlantic United States
Dariusz Hareza, Johns Hopkins Univ. School of Medicine

Evolving Epidemiology and Treatment of Invasive S. aureus Infections in Children
Sheldon Kaplan, Texas Children’s Hospital and Baylor College of Medicine

Intrinsic Antibiotic Resistance in Pseudomonas aeruginosa
Barbara Kazmierczak, Yale Univ.

Basis of Commensal Bacillota Resistance to a Novel PolC-type DNA Polymerase III Inhibitor, Ibezapolstat, and the “Narrower” Spectrum of Activity Towards Clostridioides difficile
Jacob McPherson, University of Houston

Novel Therapeutics Against Fungal Infections
Minh-Hong Nguyen, University of Pittsburgh, Pittsburgh, PA

Penicillin Resistance in Group A streptococci
Randy Olsen, Houston Methodist and Weill Cornell Medical College

Probiotics for Staphylococcus aureus: A Translational Approach
Michael Otto, NIH

Novel Dug Combinations to Address Antimicrobial Resistance
Warren Rose, Univ. of Wisconsin

Discovering Disparities in Clinical Characteristics and Outcomes Among Patients Treated in US Hospitals for Carbapenem-resistant Enterobacterales (Bloodstream) Infections
Felicia Ruffin, Duke University

Elucidating Molecular Mechanisms Underlying Successful Adaptation to Carbapenem Antimicrobials in High Risk Carbapenem Resistant Escherichia coli Lineages
William Shropshire, MD Anderson Cancer Center

Protecting Patients. Combating Antimicrobial Resistance. An Update from CDC
Arjun Srinivasan, Division of Healthcare Quality Promotion CDC

Functional Genomics of Difficult-to-Treat Enterococcal Isolates and Their Viral Adversaries
Madison E. Stellfox, Univ. of Pittsburgh

Emerging S. aureus Antimicrobial Resistance and Current Prescribing Practices for Patients Presenting to US Emergency Departments with a Purulent Skin and Soft Tissue Infection
Jesus Torres, University of California, Los Angeles, David Geffen School of Medicine

Within-host Evolution of Staphylococcus aureus Stringent Response Impart Growth Advantage Under Nutrient Stress
Edwin Chen

An Epidemiological Exploration of Reduced Vancomycin Susceptibility in Clostridioides difficile and Impact on Patient Outcomes
Taryn Eubank

Epidemiology and Management of Carbapenem-Resistant Acinetobacter baumannii (CRAB)
Keith Kaye

Discovering New Antibiotics from Unlikely Sources
Kim Lewis

Deploying New B-lactam/B-lactamase Inhibitors in Clinical Practice
Erin McCreary

Mechanisms of Cell Envelope Defense Against Antibiotics in Gram-positive Bacteria
William Miller

The Long and Short of it: Assessing Antibiotic Duration for Common Pediatric Infections
Michelle Mitchell

Making the SCENE: Interim Results from the SCENE Study and Carbapenemases in XDR Pseudomonas
Michael Satlin

Bacteriophage Therapy In Recurrent Vancomycin-Resistant E. faecium bacteremia
Madison Stellfox

A Statewide Registry for MDROs: Illinois’ Experience
William Trick

Drug Efflux in Gram-negative Bacteria
Helen Zgurskaya

Combined Genotypic and Phenotypic Antibiotic Susceptibility Testing Through Gene Expression Profiling  
Roby Bhattacharyya

Making the Cut: Antimicrobial Stewardship in Surgery
Rachel Britt

Mutations that Inactivate the Tricarboxylic Acid Cycle in Staphylococcus aureus Arise During Persistent MRSA Bacteremia
Edwin Chen

An Update on COVID-19 Vaccines
Hana El Sahy

An Epidemiologic Exploration of Vancomycin Resistance in Clostridioides difficile
Taryn Eubank

Development of Novel Antifungals Against Candida Based on an Antifungal Peptide Produced by E. faecali
Shantanu Guha

Combination Eravacycline Therapy for Carbapenem-Resistant Acinetobacter baumannii Pneumonia
Melissa Jackson

The Ribosome as an Antimicrobial Target
Alexander Mankin

Anatomy of an Extensively Drug Resistant Klebsiella pneumoniae Outbreak in Tuscany, Italy
Melissa Martin

Impact of the Pandemic on Antimicrobial Resistance
Priya Nori

Combination Therapies for Gram-positive Bacteria
George Sakoulas

Lost in Translation: Developing Novel Antibiotics Against Bacterial Ribosome Rescue
Pooja Srinivas

Antifungal Susceptibility Testing of Molds: When, Why, and How
Nathan Wiederhold

ARLG Fellowship
Judith Anesi

A Master Protocol for Simultaneous Evaluation of Multiple Diagnostic Assays to Detect N. gonorrhoeae and C. trachomatis in Extragenital Sites: MASTER GC
Sarah B. Doernberg

Antimicrobial Stewardship: The Veteran Health System Experience
Matthew B. Goetz

Whole Genome Sequencing Surveillance for Prevention of Antibiotic-Resistant Infections
Lee Harrison

Dalbavancin as an Option for Treatment of S. aureus Bacteremia: The DOTS Trial
Thomas L. Holland

Whole Genome Sequencing and Detection of Resistance in the Routine Clinical Laboratory
Robin Patel

The Role of Prevention in Healthcare Associated Infections and Antimicrobial Resistance (AMR)
Trish M. Perl

(Re)focusing Antimicrobial Stewardship Efforts on Improving Patient Outcomes
Jason M. Pogue

Rapid Diagnostics to Categorize Acute Lung Infections (RADICAL)
Ephraim L. Tsalik

The Joint Commission’s Antimicrobial Stewardship Standards
David W. Baker

Genomically Informed Pathogen Surveillance
Lynn Bry

Plasmids and Antibiotic Resistance: Novel Insights into Bacterial Sex
Alessandra Carattoli

Dysbiosis and Restoration of the Intestinal Microbiota
Herbert L. DuPont

Antibiotic Resistance: The Rationale for Strategy Trials
Vance G. Fowler, Jr.

Antibiotic Stewardship and the Quality Connection
Michael Hill